Treating adenocarcinoma with bevacizumab
Treating adenocarcinoma with bevacizumab
Myc inhibition in pre-clinical mouse models
Closing the cancer divide: Implementing the diagonal approach
Utility of robotics in the management of CT detected lung nodules
Inequalities in cancer incidence, mortality and survival
Influence of cachexia on chemotherapy toxicity
Patient involvement in improvements in standard of care
Chemotherapy and radiotherapy in advanced local non-small cell lung cancer
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)
MET inhibitors for non-small cell lung cancer
Treatment of ALK+ lung cancer with crizotinib, Profile 1007
Phase I study examining PI 3 kinase inhibitor for various tumours